Clinical Trials Directory

Trials / Completed

CompletedNCT00153309

Program Evaluation of People With Arthritis Can Exercise

Evaluation of the Health Benefits of the People With Arthritis Can Exercise Program

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
320 (planned)
Sponsor
Centers for Disease Control and Prevention · Federal
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the health and arthritis-specific benefits of participation in the Arthritis Foundation People with Arthritis Can Exercise program and to collect information to improve community-based dissemination of this program.

Detailed description

Only about 24% of people with arthritis report sufficient physical activity to provide general health benefits. Research has demonstrated that many people with arthritis can safely exercise to improve fitness and health. The People with Arthritis Can Exercise (PACE) program, developed by the Arthritis Foundation, is a land-based recreational physical activity and exercise program. PACE has been offered as a community-based program for over 10 years and small studies have reported benefits for people with arthritis. However, there has been no randomized controlled community trials that evaluate the effectiveness of PACE in the community. The goals of the Evaluation of PACE project are to: (1) appropriately evaluate the AF PACE exercise program, and (2) provide information to support effective content, recruitment and programming. Specific objectives for meeting these goals include: 1. Identify the theoretical foundations and constructs for evaluating the program and select and use appropriate outcome measures; 2. Plan and conduct a randomized controlled trial of 8 and 16 week PACE programs; 3. Perform a qualitative evaluation using focus groups of PACE instructors and participants; 4. Disseminate findings and make recommendations.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPeople with Arthritis Can Exercise

Timeline

Start date
2003-06-01
Completion
2005-06-01
First posted
2005-09-12
Last updated
2005-11-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00153309. Inclusion in this directory is not an endorsement.